Business Wire03.16.20
Carestream Health was awarded 37 new patents in 2019 by the U.S. Patent and Trademark Office for advances in digital radiography, mobile imaging X-ray systems and other healthcare technology areas. The company also received 38 patents in European and Asian countries last year, earning a total of 75 patents.
“These patents demonstrate Carestream’s prowess in developing digital imaging technologies to meet medical imaging needs in the United States and worldwide,” said Eugene Shkurko, intellectual property counsel at Carestream. “Our researchers are continuously working to enhance diagnostic image quality and user workflow. We are committed to advancing the field of medical imaging as a whole to improve the delivery of care and ultimately benefit patients.”
Patents earned by Carestream’s scientists and engineers in 2019 include:
Carestream’s product portfolio includes 2D and 3D digital medical imaging systems for general radiology and specialty areas such as pediatrics and orthopaedics, as well as digital laser imagers that output medical images to film.
In January, the U.S. Food and Drug Administration granted Carestream’s Digital Tomosynthesis (DT) functionality—a three-dimensional extension of general radiography—510(k) clearance.
Simplifying workflow and reducing exam time, DT technology is an upgradable option on the CARESTREAM DRX-Evolution Plus System, a versatile digital radiography system that can perform a wide range of general radiographic exams.
Digital Tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation. As a result, it can generate data from a series of low dose X-ray images of the same organ, taken at the same X-ray exposure, from different angles.
“The images captured by Digital Tomosynthesis technology offer greater depth and enhanced visualization,” said Sarah Verna, Worldwide Marketing Manager for Global X-ray Solutions at Carestream. “Doctors and radiologists will be able to perform scans quickly, providing valuable clinical information for further diagnosis while improving the workflow in an X-ray room.”
Digital Tomosynthesis, like a computed tomography (CT) scan, can produce cross-sectional images of an organ, allowing for increased visibility. This capability enhances the DRX-Evolution Plus in situations where physicians need quick answers.
“In trauma centers, CT rooms are always overbooked and there’s always a wait,” Verna said. “Now a doctor can further examine any body part, including the chest or lungs, with Digital Tomosynthesis because it generates many image slices, which helps sharpen diagnosis and make medical treatment more efficient. Digital Tomosynthesis does not replace computed tomography and can be used in conjunction with it.”
“These patents demonstrate Carestream’s prowess in developing digital imaging technologies to meet medical imaging needs in the United States and worldwide,” said Eugene Shkurko, intellectual property counsel at Carestream. “Our researchers are continuously working to enhance diagnostic image quality and user workflow. We are committed to advancing the field of medical imaging as a whole to improve the delivery of care and ultimately benefit patients.”
Patents earned by Carestream’s scientists and engineers in 2019 include:
- New medical image capture technologies related to long-length imaging using a single X-ray exposure for full spinal and extremity imaging
- Mobile X-ray cart technology that enables bedside imaging in selectable modes: projection radiography, tomosynthesis and fluoroscopy; and
- Technology advances in image quality delivered by Carestream’s growing portfolio of radiology imaging detectors with processing capabilities to calibrate and correct X-ray images in the detector before transmission.
Carestream’s product portfolio includes 2D and 3D digital medical imaging systems for general radiology and specialty areas such as pediatrics and orthopaedics, as well as digital laser imagers that output medical images to film.
In January, the U.S. Food and Drug Administration granted Carestream’s Digital Tomosynthesis (DT) functionality—a three-dimensional extension of general radiography—510(k) clearance.
Simplifying workflow and reducing exam time, DT technology is an upgradable option on the CARESTREAM DRX-Evolution Plus System, a versatile digital radiography system that can perform a wide range of general radiographic exams.
Digital Tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation. As a result, it can generate data from a series of low dose X-ray images of the same organ, taken at the same X-ray exposure, from different angles.
“The images captured by Digital Tomosynthesis technology offer greater depth and enhanced visualization,” said Sarah Verna, Worldwide Marketing Manager for Global X-ray Solutions at Carestream. “Doctors and radiologists will be able to perform scans quickly, providing valuable clinical information for further diagnosis while improving the workflow in an X-ray room.”
Digital Tomosynthesis, like a computed tomography (CT) scan, can produce cross-sectional images of an organ, allowing for increased visibility. This capability enhances the DRX-Evolution Plus in situations where physicians need quick answers.
“In trauma centers, CT rooms are always overbooked and there’s always a wait,” Verna said. “Now a doctor can further examine any body part, including the chest or lungs, with Digital Tomosynthesis because it generates many image slices, which helps sharpen diagnosis and make medical treatment more efficient. Digital Tomosynthesis does not replace computed tomography and can be used in conjunction with it.”